Oramed Pharmaceuticals Inc
ORMP2.985USD
+0.055+1.88%
Market hours （ET）Quotes delayed by 15 min
121.90MMarket Cap
2.84P/E TTM
Oramed Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-0.47
-440.63%
Analyst Rating
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.467, with a year-on-year change of -440.63%.
What is the net income of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its net income was -19.06M, with a year-on-year change of -444.98%.
What is the net margin of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -12.29%, with a year-on-year change of -451.15%.
What is the Return on Assets (ROA) of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -10.17%, with a year-on-year change of -481.81%.
What is the operating profit of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -12.78M, with a year-on-year change of 18.95%.
What are the current assets of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its current assets were 143.22M, with a year-on-year change of -11.91%.
What are the total assets of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its total assets of Oramed Pharmaceuticals Inc were 155.28M, with a year-on-year change of -29.60%.
What are the total liabilities of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Oramed Pharmaceuticals Inc were 9.93M, with a year-on-year change of -82.78%.
What is the total equity of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its total equity of Oramed Pharmaceuticals Inc was 145.35M, with a year-on-year change of -10.77%.
What is the net operating income of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Oramed Pharmaceuticals Inc was -19.10M, with a year-on-year change of -475.45%.
What is the net investment of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its net investment of Oramed Pharmaceuticals Inc was 105.82M, with a year-on-year change of 244.88%.
What is the net financing of Oramed Pharmaceuticals Inc?
According to Oramed Pharmaceuticals Inc's FY2024 earnings report, its net financing of Oramed Pharmaceuticals Inc was -52.04M, with a year-on-year change of -200.11%.
